REGN-17092
- Generic Name
- REGN-17092
A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 40
- Registration Number
- NCT05923424
- Locations
- 🇧🇪
UZ Leuven Gasthuisberg Campus, Leuven, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath